Day: April 6, 2023

HORSHAM, Pa., April 06, 2023 (GLOBE NEWSWIRE) — Bimbo Bakeries USA, Inc. is teaming up with Walmart for its 2023 “Fight Hunger. Spark Change.” campaign. Now in its tenth year, the campaign works with local Feeding America® food banks to help secure meals for those facing food insecurity. Each day one in eight Americans faces hunger and food insecurity, a problem affecting every community in the country. To help combat this issue, Walmart is working with national brands and organizations to benefit all 200 Feeding America member food banks. From April 10, 2023, until May 8, 2023, Bimbo Bakeries USA will donate to Feeding America for each purchase of participating Bimbo Bakeries USA bread and breakfast products at Walmart from Sara Lee® and Nature’s Harvest® Brands. One dollar helps secure at least 10 meals for local member food...

GREENWICH, Conn., April 06, 2023 (GLOBE NEWSWIRE) — American Battery Materials, Inc. (OTC Pink: BOXS) (“ABM”, the “Company”), an environmentally responsible minerals exploration and development company focused on direct lithium extraction (DLE) and other critical minerals for the global energy transition, announced that management has completed a bridge financing to support the continuing development of its Lisbon Valley Clean Lithium Project.   Sebastian Lux, co-Chief Executive Officer of ABM, stated, “We continue to make steady operational progress on all our growth initiatives. With 120 mining claims filed, all of which are in good standing with the Bureau of Land Management, this financing should allow us to commence the geological and drilling projects that we have been working diligently on. We anticipate that the findings...

Changzhou City, China, April 06, 2023 (GLOBE NEWSWIRE) — Jin Medical International Ltd. (the “Company” or “JinMed”) (NASDAQ: ZJYL), a Cayman Islands holding company with Chinese operating entities that manufacture and develop wheelchairs and living aids products, today announced that Prime Number Capital, LLC, as the representative of the underwriters of the Company’s initial public offering (“IPO”), has partially exercised the over-allotment option to purchase an additional 47,355 ordinary shares at the IPO price of $8.00 per share. As a result, the Company has raised gross proceeds of $378,840, in addition to the previously announced IPO gross proceeds of $8,000,000, before deducting underwriting discounts and offering expenses. Prime Number Capital, LLC acted as the sole bookrunner for the IPO. SBI China Capital...

The company announces that the general shareholders meeting will take place at later date then planned on initial version of investor‘s calendar.  Below we present current version of Company’s investor’s calendar: 14 04 2023               Revenue and clients for March period20 04 2023              AB Novaturas strategy for years 2023 – 202515 05 2023               Revenue and clients for April period30 05 2023               Interim consolidated financial statements for 3 months of 2023Till 31 05 2023          Decisions of General Meeting of Shareholders15 06 2023               Revenue and clients for May period14 07 2023               Revenue and clients for June period14 08 2023               Revenue and clients for July period29 08 2023               Interim consolidated financial statements for 6 months of 202315 09 2023             ...

Report details new data, trends, and strategies for pediatric healthcare organizations LINCOLN, Neb., April 06, 2023 (GLOBE NEWSWIRE) — NRC Health, the leading partner in building Human Understanding® through personalized healthcare solutions and data-driven insights, today released its 2023 Pediatric Experience Perspective and trends report. The report takes a broad view of the pediatric healthcare experience and highlights how the power of Human Understanding can reframe the fundamentals of pediatric healthcare. Providing excellent care for children, adolescents and their families requires a deep understanding of individual circumstances, needs, and expectations. The lack of three things – emotional support, listening, and time spent with patients – appears to offer a direct path to disappointing patients and families. In fact,...

50% of All Respondents Have Purchased Products After Seeing them Used by InfluencersIZEA Research Reveals 42% of Gen Z Turns to TikTok Before Making Major Purchases 50% of All Respondents Have Purchased Products After Seeing them Used by InfluencersOrlando, Florida, April 06, 2023 (GLOBE NEWSWIRE) — IZEA Worldwide, Inc. (NASDAQ: IZEA), the premier provider of influencer marketing technology, data, and services for the world’s leading brands, released its latest research report, “Trust in Influencer Marketing,” today. The report is based on U.S. consumer sentiment and examines the effectiveness of influencer marketing in terms of consumer trust and engagement.  The survey found that 31% of respondents ages 18-29 named TikTok as their preferred platform for influencing, up from 19% in the 2022 report. TikTok’s growing influence...

NEWPORT NEWS, Va., April 06, 2023 (GLOBE NEWSWIRE) — HII (NYSE:HII) will release its first quarter 2023 financial results on Thursday, May 4 and host an earnings conference call at 9 a.m. Eastern time the same day. The call will be webcast live on HII’s website: https://www.hii.com/. HII participants will include Chris Kastner, president and CEO, and Tom Stiehle, executive vice president and chief financial officer. Their remarks will be supplemented by a series of slides appearing on the company website. Listeners are encouraged to view these materials in conjunction with the call. Replays of the call will be available on the website for a limited time. HII is a global, all-domain defense provider. HII’s mission is to deliver the world’s most powerful ships and all-domain solutions in service of the nation, creating the advantage...

Analysis of Open-Label Portion of Ongoing Phase 2 Trial of GEO-CM04S1 Presented at 23rd Annual World Vaccine Congress Atlanta, GA, April 06, 2023 (GLOBE NEWSWIRE) —  via NewMediaWire – GeoVax Labs, Inc. (Nasdaq: GOVX), a biotechnology company developing immunotherapies and vaccines against cancers and infectious diseases, presented an update on the development of its SARS-CoV-2 vaccine, GEO-CM04S1, including preliminary data from an ongoing Phase 2 clinical trial, during the 23rd Annual World Vaccine Congress taking place in Washington, DC. The presentation, titled “COVID-19 Vaccine CM04S1; A Superior Viral Platform Alternative for Eliciting Durable T Cell Responses in Immunocompromised Hematologic Malignancy Patients,” was delivered by Dr. Don Diamond, Department of Hematology & Hematopoietic Cell Transplantation, City of...